Pepticom is a biotechnology company based in Jerusalem, Israel. Founded in 2011, it focuses on developing novel peptide drug candidates. The company utilizes biocomputational AI-driven software to optimize the entire drug discovery process, reducing development costs and risks and accelerating time to market.